Alembic Pharmaceuticals receives 2 observations for Gujarat facility from USFDA

As per US Food and Drug Administration (USFDA), Form 483 is issued to a firm's management at the conclusion of an inspection when the investigator has observed any conditions that may constitute violations of the Food Drug and Cosmetic (FD&C) Act and related Acts.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/efPENi9
via IFTTT